Close X
Monday, November 11, 2024
ADVT 
National

Moderna to test its COVID vaccine on Canadian kids

Darpan News Desk The Canadian Press, 17 Mar, 2021 06:44 PM
  • Moderna to test its COVID vaccine on Canadian kids

Moderna says upcoming clinical trials for its COVID-19 vaccine will include Canadian children, but experts say it's unlikely students will receive one before the next school year in September.

The company announced details of its Phase 2/3 study of COVID-19 earlier this week. It’s expected to involve 6,750 healthy pediatric participants aged six months to 12 years.

Moderna says initial participants are based in the United States but that Canadian sites will be added as the trial progresses.

The biotech company says it hasn't yet chosen the Canadian sites, nor Canadian participants.

Moderna CEO Stephane Bancel says it's an important age group to study.

The trial will evaluate the safety and effectiveness of two doses given 28 days apart. Participants will be followed for one year after the second vaccination.

In addition to Moderna, Canada has approved vaccines by Pfizer-BioNTech and Oxford-AstraZeneca for adult use, although the Pfizer product can be used by people as young as 16.

Dr. Caroline Quach of the National Advisory Committee on Immunization said Tuesday that she expected to see trial data from Pfizer involving 12-to-15-year-olds in two-to-three months.

But she said she didn’t expect one would be ready and approved for Canadian children before the end of the year.

AstraZeneca has also started a trial with younger age groups, while Johnson & Johnson is expected to run a vaccine trial involving teens this spring in Toronto and Burlington, Ont.

But like Quach, Health Canada's chief medical adviser did not expect to have a vaccine ready for children by the time school starts in September.

"I think that timeline may be a bit optimistic," Dr. Supriya Sharma said earlier this month.

"The trials in children tend to be a bit slower to get up and running in terms of recruiting individuals. And then of course, we have to conduct the trials and then take that information and assess that.

"It’s not inconceivable that we might have some data in the summer, and potentially by the end of this calendar year we might have some indications in children, but that's still pretty optimistic."

MORE National ARTICLES

Copper deadly to bacteria, study shows

Copper deadly to bacteria, study shows
As part of its response to the COVID-19 pandemic, TransLink was the first transit agency in North America to test copper on high-touch surfaces.

Copper deadly to bacteria, study shows

Fourth vaccine approval expected in days

Fourth vaccine approval expected in days
If that happens it will add a fourth option to Canada's efforts to immunize our way to an end to the pandemic and the first to require only one dose.

Fourth vaccine approval expected in days

Premiers put pre-budget pressure on Ottawa

Premiers put pre-budget pressure on Ottawa
They argue the federal government shoulders only 22 per cent of the cost of health care; their demand would increase that share to 35 per cent.

Premiers put pre-budget pressure on Ottawa

Feds tap transit funds for electric buses

Feds tap transit funds for electric buses
The hope is that the $2.75 billion in traditional grant money will dovetail with the $1.5 billion an infrastructure-financing agency is supposed to invest toward the same cause.

Feds tap transit funds for electric buses

Crown lawyer urges Meng's judge to ignore politics

Crown lawyer urges Meng's judge to ignore politics
Meng is wanted in the United States on fraud charges that both she and Huawei deny.

Crown lawyer urges Meng's judge to ignore politics

Vancouver makes plan to cut Canada goose numbers

Vancouver makes plan to cut Canada goose numbers
A statement from the Vancouver Board of Parks and Recreation says it is developing a management plan to reduce the number of geese in city parks, beaches and on the seawall.

Vancouver makes plan to cut Canada goose numbers